US Food and Drug Administration approved the world’s first production and use of tablets, printed the 3D-printer. Previously, the FDA approved the use of medical devices prosthetic obtained in the same manner.
The new drug, called Spritam, Aprecia Pharmaceuticals was developed to control seizures caused by epilepsy. According to the company, in the future it is planned to develop other drugs on the basis of 3D-platform.
The use of 3D-printers enables packaging drugs with more accurate dosage and a special technology developed by, and is known as ZipDose, allows easier ingestion of high doses of drugs. This means that one can fit the tablet to 1000 mg of the drug.
3D-soluble tablets in the same manner as other oral medications. Furthermore, in the future it will be possible to print the tablets based on the individual needs of a particular patient. This will mean that hospitals will be able to adjust the dose for individual patients through a simple configuration software provided before printing. Previously, these options were too expensive.
Such techniques have proven effective in the use of health care systems to create custom implants for patients with injuries or other conditions. Doctors, for example, use 3D-printers to create replicas of the jaws and teeth and other dental implants.